Lipid management for woman requires personalized care that considers sex-specific conditions across the reproductive lifespan ...

India has officially approved and launched Mounjaro (tirzepatide), a groundbreaking injectable medication for the treatment of Type 2 diabetes and obesity. Developed by Eli Lilly and Company, the drug ...

In a bold move to address the growing epidemic of lifestyle diseases in India, Redial Clinic has launched a nationwide initiative focused on reversing type 2 diabetes, hypertension, and obesity ...

Health workers have long relied on Body Mass Index as a way to measure whether people are within a healthy weight range. Now, a collection of top researchers have made the case for a new way to ...

The experiment was a striking attempt to investigate weight control. For six weeks, a group of mice gorged on lard-enriched ...

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Gary Miller remembers being told by a [former] doctor that his fatty liver disease was a “benign condition.”“This doctor ...

Semaglutides, which are used to treat type 2 diabetes and obesity, were the most-sold medication in Finland last year, ...

SO-CALLED “miracle” weight-loss jabs are far less effective in the real world than in clinical trials, a major study has revealed. The new findings could have big implications for Brits ...

Indian contract drug manufacturer OneSource Specialty Pharma expects strong growth in its order book over the next three years, driven by the global boom in weight-loss drugs, its top executive said ...

In that light, the GLP-1 rebound effect is not an obstacle but an opportunity to chart a new, holistic course in obesity care ...

Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...